These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19670296)

  • 61. Ultrastructural changes of the gemifloxacin on Achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin.
    Bae CS; Oh DM; Bae JG; Kim JC; Kim SH; Kim SG; Jeong MJ; Kim YS; Lim SC
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):406-10. PubMed ID: 16623866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling.
    van den Brink WJ; Wong YC; Gülave B; van der Graaf PH; de Lange EC
    AAPS J; 2017 Jan; 19(1):274-285. PubMed ID: 27785749
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
    Azoulay-Dupuis E; Bédos JP; Mohler J; Moine P; Cherbuliez C; Peytavin G; Fantin B; Köhler T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1046-54. PubMed ID: 15728901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
    Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P
    Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetic-pharmacodynamic modelling in the early development phase of anti-psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats.
    Parker TJ; Della Pasqua OE; Loizillon E; Chezaubernard C; Jochemsen R; Danhof M
    Br J Pharmacol; 2001 Jan; 132(1):151-8. PubMed ID: 11156572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats.
    Delon A; Bouquet S; Huguet F; Brunet V; Courtois P; Couet W
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1511-5. PubMed ID: 10348785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions.
    Mandema JW; Veng-Pedersen P; Danhof M
    J Pharmacokinet Biopharm; 1991 Dec; 19(6):617-34. PubMed ID: 1815044
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The application of population pharmacokinetic modeling to individualized antibiotic therapy.
    Vinks AA
    Int J Antimicrob Agents; 2002 Apr; 19(4):313-22. PubMed ID: 11978502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetic-pharmacodynamic modeling of tolmetin antinociceptive effect in the rat using an indirect response model: a population approach.
    Flores-Murrieta FJ; Ko HC; Flores-Acevedo DM; López-Muñoz FJ; Jusko WJ; Sale ME; Castañeda-Hernández G
    J Pharmacokinet Biopharm; 1998 Oct; 26(5):547-57. PubMed ID: 10205770
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Retraction. Roy B, Bose A, Bhaumik U, Das A, Chatterjee N, Ghosh A, Darbar S, Sarkar AK, Sengupta P, Pal TK. 2010. Convulsant activity and pharmacokinetic–pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats. J Pharm Sci 99:1535–1547.
    J Pharm Sci; 2012 Feb; 101(2):885. PubMed ID: 22319775
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmacodynamic modeling of propofol-induced general anesthesia in young adults.
    Chakravarty S; Nikolaeva K; Kishnan D; Flores FJ; Purdon PL; Brown EN
    Health Innov Point Care Conf; 2017 Nov; 2017():44-47. PubMed ID: 32803192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats.
    Chenel M; Barbot A; Dupuis A; Mimoz O; Paquereau J; Bouquet S; Couet W
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1952-7. PubMed ID: 12760873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.
    Dupuis A; Couet W; Paquereau J; Debarre S; Portron A; Jamois C; Bouquet S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1682-7. PubMed ID: 11353611
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gemifloxacin for community-acquired pneumonia.
    Lode HM; Schmidt-Ionas M; Stahlmann R
    Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.
    Jivcu C; Gotfried M
    Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats.
    Roy B; Bose A; Bhaumik U; Das A; Chatterjee N; Ghosh A; Darbar S; Sarkar AK; Sengupta P; Pal TK
    J Pharm Sci; 2010 Mar; 99(3):1535-47. PubMed ID: 19670296
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.